Haemophilia trials in Türkiye

In Türkiye 13 Also abroad 131

13 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

No phaseNot yet taking people in Türkiye
Safety of Intraosseous Anaesthesia in Children With Haemophilia
Where
Ankara
Age
4 years to 12 years
People
20
Run by
Ankara Yildirim Beyazıt University
See details and how to joinNCT07916467
Phase 3Taking people
A Research Study Investigating Denecimig (Mim8) in Adults With Acquired Haemophilia A
Where
Ankara, Istanbul, Izmir
Age
18 years and over
People
84 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07830732 · EU 2026-525529-19-00
Phase 3Taking people
A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B
Where
Istanbul, Izmir
Age
1 year to 11 years
People
85 worldwide
Run by
Sanofi
See details and how to joinNCT07285460 · EU 2025-521858-42-00
Phase 3Taking people
Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
Where
Adana, Ankara, Gaziantep, Istanbul, Izmir, Kayseri, Samsun
Age
1 year to 74 years
People
245 worldwide
Run by
Pfizer
See details and how to joinNCT05145127 · EU 2022-500470-33-00
Phase 1Taking people
A Study to Learn About How Changing Therapy From Emicizumab to Marstacimab Affects People With the Severe Hemophilia A.
Where
Bornova, Fatih
Age
12 years to 74 years
People
15 worldwide
Run by
Pfizer
See details and how to joinNCT06703606
Phase 3Taking people
A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B
Where
Adana, Ankara, Istanbul, Izmir, Kayseri, Melikgazi, Samsun
Age
1 year to 17 years
People
100 worldwide
Run by
Pfizer
See details and how to joinNCT05611801 · EU 2022-500495-65-00
Phase 3Taking people
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
Where
Adana, Gaziantep, Istanbul, Izmir
Age
18 years and over
People
173 worldwide
Run by
Pfizer
See details and how to joinNCT05568719
No phaseTaking people
Validity and Reliability of the Figure-of-Eight Walking and Weight-Bearing Lunge Tests in Hemophilia
Where
Van
Age
18 years to 65 years
People
36
Run by
Yuzuncu Yil University
See details and how to joinNCT07851922
Phase 3Taking people
Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy in Adults With Hemophilia B With Pretreatment Adeno-associated Virus Serotype 5 (AAV5) Neutralizing Antibodies (Nabs)
Where
Bornova, Gaziantep, Seyhan
Age
18 years and over
People
35 worldwide
Run by
CSL Behring
See details and how to joinNCT06003387 · EU 2023-509590-23-00
No phaseTaking people
Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients
Where
Fatih
People
200 worldwide
Run by
Octapharma
See details and how to joinNCT03695978
No phaseTaking people
Joint Health, Balance and Quality of Life in Adults With Hemophilia A
Where
Van
Age
18 years to 65 years
People
36
Run by
Yuzuncu Yil University
See details and how to joinNCT07523399
No phaseNot yet taking people in Türkiye
Effects of Emicizumab Treatment in Patients With Hemophilia A
Where
Gaziantep
Age
1 year to 18 years
People
20
Run by
Hasan Kalyoncu University
See details and how to joinNCT07190118
No phaseEnrolling by invitation
Comparison of Upper Extremity Functional Performance in Hemophilic and Healthy Children
Where
Ankara
Age
7 years to 17 years
People
30
Run by
Hacettepe University
See details and how to joinNCT06826209